The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity

Chemistry and Biology

Volumn 7, Issue 6, 2000, Pages 423-432

  Wei, Yunyi ^a   Fox, Ted ^a   Chambers, Steve P ^a   Sintchak, Joanne ^a   Coll, Joyce T ^a   Golec, Julian M C ^a   Swenson, Lora ^a   Wilson, Keith P ^a   Charifson, Paul S ^a  

^a VERTEX PHARMACEUTICALS   (United States)

Author keywords

Caspases; Inhibitor design structure; Selectivity

Indexed keywords

EID: 0034095571     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(00)00123-X     Document Type: Article

References (48)

1. Cohen G.M. Caspases: the executioners of apoptosis. Biochem. J. 326:1997;1-16.
2. Miller D.K. The role of the Caspase family of cysteine proteases in apoptosis. Sem. Immunol. 9:1997;35-49.
3. Nunez G.B., Benedict M.A., Hu Y., Inohara N. Caspases: the proteases of the apoptotic pathway. Oncogene. 17:1998;3237-3245.
4. Stennicke H.R., Salvesen G.S. Properties of the caspases. Biochim. Biophys. Acta. 1387:1998;17-31.
5. Thornberry N.A. Caspases: key mediators of apoptosis. Chem. Biol. 5:1998;R97-R103.
6. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science. 281:1998;1312-1316.
7. Garcia-Calvo M., Peterson E.P., Leiting B., Ruel R., Nicholson D.W., Thornberry N.A. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J. Biol. Chem. 273:1998;32608-32613.
8. Ku G., Faust T., Lauffer L.L., Livingston D.J., Harding M.W. Interleukin-1β converting enzyme inhibition blocks progression of type II collagen-induced arthritis in mice. Cytokine. 8:1996;377-386.
9. Yaoita H., Ogawa K., Maehara K., Maruyama Y. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation. 97:1998;276-281.
10. Cheng Y., Holtzman D.M.et al. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J. Clin. Invest. 101:1998;1992-1999.
11. Endres M., Moskowitz M.A.et al. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J. Cerebr. Blood Flow Metabol. 18:1998;238-247.
12. Yakovlev A.G., Knoblach S.M., Fan L., Fox G.B., Goodnight R., Faden A.I. Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J. Neurosci. 17:1997;7415-7424.
13. Rodriguez I., Matsuura K., Ody C., Nagata S., Vassalli P. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against fas-mediated fulminant liver destruction and death. J. Exp. Med. 184:1996;2067-2072.
14. Giegel D.A., Kostlan C.R. Blocking interleukin-1 action. Bristol J.A. Annual Reports in Medicinal Chemistry. 1998;183-192 Academic Press, San Diego.
15. Walker N.P.C., Hammill L.D.et al. Crystal structure of the cysteine protease interleukin-1β-converting enzyme: a (p20/p10)2 homodimer. Cell. 78:1994;343-352.
16. Wilson K.P., Livingston D.J.et al. Structure and mechanism of interleukin-1β converting enzyme. Nature. 370:1994;270-275.
17. Margolin N., Livingston D.J.et al. Substrate and inhibitor specificity of interleukin-1β-converting enzyme and related caspases. J. Biol. Chem. 272:1997;7223-7228.
18. Okamoto Y., Isomura Y.et al. Peptide based-interleukin-1β converting enzyme (ICE) inhibitors: synthesis, structure activity relationships and crystallographic study of the ICE-inhibitor complex. Chem. Pharmaceut. Bull. 47:1999;11-21.
19. Rotonda J., Becker J.W.et al. The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis. Nat. Struct. Biol. 3:1996;619-625.
20. Mittl P.R.E., Grütter M.G.et al. Structure of recombinant human CPP32 in complex with the tetrapeptide acetyl-Asp-Val-Ala-Asp fluoromethyl ketone. J. Biol. Chem. 272:1997;6539-6547.
21. Blanchard H., Grütter M.G.et al. The three-dimensional structure of caspase-8: an initiator enzyme in apoptosis. Structure. 7:1999;1125-1133.
22. Watt W., Koeplinger K.A., Mildner A.M., Heinrikson R.L., Tomasselli A.G., Watenpaugh K.D. The atomic-resolution structure of human caspase-8, a key activator of apoptosis. Structure. 7:1999;1135-1143.
23. Laskowski R.A., MacArthur M.W., Moss D.S., Thornton J.M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26:1993;283-291.
24. Richardson J.S. The anatomy and taxonomy of protein structure. Adv. Protein Chem. 34:1981;167-338.
25. Ollis D.L., Remington S.J.et al. The α/β hydrolase fold. Protein Eng. 5:1992;599-611.
26. Thornberry N.A., Nicholson D.W.et al. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272:1997;17907-17911.
27. Golec J.M.C., Livingston D.J.et al. Structure-based design of non-peptidic pyridone aldehydes as inhibitors of interleukin-1β converting enzyme. Bioorg. Med. Chem. Lett. 7:1997;2181-2186.
28. Dao-Pin S., Nicholson H., Baase W.A., Zhang X.J., Wozniak J.A., Matthews B.W. Structural and genetic analysis of electrostatic and other interactions in bacteriophage T4 lysozyme. Ciba Found. Symp. 161:1991;52-62.
29. Wu J.C., Fritz L.C. Irreversible caspase inhibitors: tools for studying apoptosis. Methods. 17:1999;320-328.
30. Chandler J.M., Cohen G.M., MacFarlane M. Different subcellular distribution of caspase-3 and caspase-7 following Fas-induced apoptosis in mouse liver. J. Biol. Chem. 273:1998;10815-10818.
31. Machleidt T., Geller P., Schwandner R., Scherer G., Kronke M. Caspase 7-induced cleavage of kinectin in apoptotic cells. Fed. Eur. Biochem. Studies. 436:1998;51-54.
32. Saudou F., Finkbeiner S., Devys D., Greenberg M.E. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell. 95:1998;55-66.
33. Wellington C.L., Hayden M.R.et al. Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J. Biol. Chem. 273:1998;9158-9167.
34. Dodel R.C., Du Y., Bales K.R., Ling Z., Carvey P.M., Paul S.M. Caspase-3-like proteases and 6-hydroxydopamine induced neuronal cell death. Mol. Brain Res. 64:1999;141-148.
35. Gervais F.G., Nicholson D.W.et al. Involvement of Caspases in proteolytic cleavage of Alzheimer's amyloid-β precursor protein and amyloidogenic Aβ peptide formation. Cell. 97:1999;395-406.
36. Ona V.O., Friedlander R.M.et al. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature. 399:1999;263-267.
37. Shimohama S., Tanino H., Fujimoto S. Changes in caspase expression in Alzheimer's disease: comparison with development and aging. Biochem. Biophys. Res. Commun. 256:1999;381-384.
38. Thornberry N.A., Aunins J.et al. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature. 356:1992;768-774.
39. Gu Y., Sarnecki C., Fleming M.A., Lippke J.A., Bleackley R.C., Su M.S.-S. Processing and activation of CMH-1 by granzyme B. J. Biol. Chem. 271:1996;10816-10820.
40. Lippke J.A., Gu Y., Sarnecki C., Caron P.R., Su M.S.-S. Identification and characterization of CPP32/Mch2 homolog 1, a novel cysteine protease similar to CPP32. J. Biol. Chem. 271:1996;1825-1828.
41. Chen W., Raybuck S.A., Fulghum J.R., Petrillo R.A., Margolin N., Chambers S.P. Expression and purification of human interleukin-1β converting enzyme form Trichoplusia in insect cells using a baculovirus expression system. Protein Expr. Purif. 9:1997;69-75.
42. Navaza J. AMoRe: an automated package for molecular replacement. Acta Crystallogr. A. 50:1994;157-163.
43. Brunger A. X-PLOR, A System for X-ray Crystallography and NMR. 1996;Yale University Press, New Haven.
44. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:1997;307-326.
45. Matthews B.W. Solvent content of protein crystals. J. Mol. Biol. 33:1968;491-497.
46. Carson M. Ribbons 2.0. J. Appl. Cryst. 24:1991;958-961.
47. Lambert M.H. Docking conformationally flexible molecules into protein binding sites. Charifson P.S. Practical Applications of Computer-Aided Drug Design. 1997;243-303 Dekker, New York.
48. Nicholls A., Sharp K.A., Honig B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins. 11:1991;281-296.